Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Research ArticleOriginal Research

Effect of High-Flow Nasal Cannula on Thoraco-Abdominal Synchrony in Pediatric Subjects After Cardiac Surgery

Taiga Itagaki, Nobuto Nakanishi, Nao Okuda, Emiko Nakataki, Mutsuo Onodera, Jun Oto and Masaji Nishimura
Respiratory Care January 2019, 64 (1) 10-16; DOI: https://doi.org/10.4187/respcare.06193
Taiga Itagaki
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuto Nakanishi
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nao Okuda
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emiko Nakataki
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mutsuo Onodera
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Oto
Department of Emergency and Disaster Medicine, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaji Nishimura
Emergency and Critical Care Medicine, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

BACKGROUND: We previously reported the effects of high-flow nasal cannula (HFNC) oxygen therapy on thoraco-abdominal synchrony. This study was designed to clarify the effect of HFNC on thoraco-abdominal synchrony in pediatric subjects after cardiac surgery and to investigate HFNC optimal flow in this population.

METHODS: Thoraco-abdominal synchrony was evaluated with respiratory inductive plethysmography. After extubation, we delivered oxygen via face mask for 30 min to subjects with mild to moderate respiratory failure. Each subject then randomly received either 1 or 2 L/kg/min via HFNC for 30 min, followed by the other flow level via HFNC for 30 min. After HFNC, face mask delivery was resumed. Rib cage and abdominal movement were converted into volumes and 2 quantitative indexes: maximum compartmental amplitude/tidal volume (VT) ratio and phase angle.

RESULTS: Ten subjects of median (interquartile range) age 7 (6–14) months and weighing 6.5 (5.3–8.8) kg were enrolled. Compared with the first delivery via face mask, breathing frequency, maximum compartmental amplitude/VT, phase angle, and minute volume significantly decreased at 2 L/kg/min (P < .05 for all) but not at 1 L/kg/min. PaCO2 did not differ among oxygen therapies. None of the measured variables differed between first and second face mask periods.

CONCLUSIONS: After cardiac surgery, HFNC oxygen therapy at 2 L/kg/min improved thoraco-abdominal synchrony and decreased breathing frequency in pediatric subjects. (Clinical trial registration: UMIN000023426.)

  • high-flow nasal cannula
  • neonates
  • thoraco-abdominal synchrony
  • cardiac surgery
  • oxygen therapy

Introduction

High-flow nasal cannula (HFNC) oxygen therapy is now a commonly used means of respiratory support for critically ill patients with respiratory failure.1–5 Despite its popularity, a convincing level of evidence is lacking in children.6–8 For subjects of all ages, a number of physiological advantages have been evaluated, including adequate humidification,9,10 positive airway pressure,11,12 washout of nasopharyngeal dead space,13,14 and stable FIO2.10,15 The physiological effects of HFNC on children have been investigated mostly in premature infants,16,17 and data for other pediatric subjects are lacking.18

Patients with respiratory failure often exhibit impaired coordinated movement of the chest and abdomen, resulting in increased work of breathing.19,20 Previously, we studied the effect of HFNC on the movement of the chest and abdomen in adult subjects with mild to moderate respiratory failure.21 HFNC improved thoraco-abdominal synchrony and decreased breathing frequency while PaCO2 was constant. Then we discussed washout of anatomical dead space as a possible mechanism of the improved breathing pattern. Despite the wide use of HFNC in the management of critically ill children with respiratory insufficiency from heart failure, cardiac surgery, and neuromuscular weakness as well as obstructive airway diseases, such as bronchiolitis, almost all of the published data for its effect on the breathing pattern of pediatric subjects has been derived from preterm infants.20,22,23 In addition, the optimal flow for pediatric subjects has yet to be determined. HFNC generates positive airway pressure and may reduce work of breathing in a flow-dependent manner.8,11,16 However, the increase in airway pressure is unpredictable due to many factors, such as mouth opening, and may not have a linear relationship with set flow.24,25

The aim of this study was to determine whether HFNC improved thoraco-abdominal synchrony in pediatric subjects with mild to moderate respiratory failure after cardiac surgery. In addition, from the viewpoint of thoraco-abdominal synchrony, we examined the effect of flow level for pediatric subjects.

QUICK LOOK

Current knowledge

High-flow nasal cannula (HFNC) oxygen therapy improves thoraco-abdominal synchrony and reduces breathing frequency in adult patients with moderate hypoxemic respiratory failure. The impact of HFNC and flow level on breathing pattern has not been described in pediatric subjects.

What this paper contributes to our knowledge

In pediatric subjects with mild to moderate respiratory failure after cardiac surgery, HFNC oxygen therapy at 2 L/kg/min flow improved thoraco-abdominal synchrony by improving the phase angle and the ratio of maximum compartmental amplitude to tidal volume and decreasing breathing frequency.

Methods

We conducted a prospective crossover study in a university hospital ICU. Ethical approval for this study (protocol number 1492) was provided by the ethics committee of Tokushima University Hospital. Written informed consent was obtained from parents.

Subject Enrollment

Pediatric subjects with body weight of 2–10 kg were surveyed. We included subjects with mild to moderate respiratory failure who presented with one or more of the following after extubation: SpO2 < 95% without supplemental oxygen (for acyanotic heart disease); breathing frequency > 50 breaths/min; asynchronous or paradoxical breathing pattern. The exclusion criteria were: mean blood pressure < 40 mm Hg for neonates and < 50 mm Hg for infants; PaO2/FIO2 < 150 mm Hg (for acyanotic heart disease); pH < 7.2 and PaCO2 > 60 mm Hg; facial trauma or nasal obstruction; and inability to tolerate HFNC.

Study Protocol

Thoraco-abdominal movements were measured with respiratory inductive plethysmography (Inductotrace, Ambulatory Monitoring, Ardsley, New York) via 2 elastic transducers (Inductobands, Ambulatory Monitoring) placed around the thorax and abdomen to record changes in cross-sectional area.

After extubation, we observed the subjects under ambient conditions for 5 min. Each subject that met the inclusion criteria was enrolled into the study, and conventional oxygen therapy was applied to deliver oxygen via a loosely attached standard face mask (OX-130, Atom Medical, Saitama, Japan), at 0–3 L/min. Flow was titrated to keep SpO2 at ≥ 95%. After 30 min, we measured thoraco-abdominal movement, heart rate, blood pressure, breathing frequency, and SpO2 and drew an arterial blood sample for blood gas analysis. We then applied the HFNC through a system composed of an air-oxygen blender (San-You Technology, Saitama, Japan), a heated humidifier (MR850, Fisher & Paykel Healthcare, Auckland, New Zealand), a breathing circuit (RT330, Fisher & Paykel Healthcare), and a nasal cannula (OPT312/314/316, Fisher & Paykel Healthcare). The breathing circuit included a heating wire and a pressure-relief valve to keep circuit pressure at < 45 cm H2O. Nasal cannula size was chosen to enable leakage at the nose by occluding approximately half the nares.

We evaluated the effect of HFNC at 2 flow levels within the maximum flow that the manufacturer claimed for each nasal cannula. HFNC flow of 1 and 2 L/kg/min were consecutively applied in digitally randomized order (ie, initial gas flow was 1 L/kg/min for 30 min, followed by 2 L/kg/min for 30 min in some subjects, and vice versa for the others). At the end of each 30-min protocol, we measured thoraco-abdominal movement, heart rate, blood pressure, breathing frequency, and SpO2 and drew arterial blood for blood gas analysis. After the HFNC protocols, conventional oxygen therapy was resumed, and the same measurements were taken after 30 min. The study was stopped and routine management resumed if subjects revealed intolerance for HFNC, severe upper-airway obstruction, or acidosis pH < 7.3 with PaCO2 > 50 mm Hg.

Measurement of Thoraco-Abdominal Movement

We calibrated respiratory inductive plethysmography using the qualitative diagnostic calibration technique described by Sackner et al26 The motions of the rib cage and abdomen were evaluated from changes in the inductance of the transducers during respiratory support via oronasal mask and HFNC. Signals were recorded, and the data were later analyzed with a software application (WINDAQ, DATAQ Instruments, Akron, Ohio). The arithmetic sums of the maximal peak-to-trough amplitudes of rib cage and abdomen excursions represent the maximum compartmental amplitudes. The algebraic sum of rib cage and abdomen excursions represents the tidal volume (VT). We then calculated the ratio of maximum compartmental amplitude to VT. Plotting abdominal motion against rib cage motion, we also created Konno–Mead diagrams. Phase angle (θ) was calculated using the formula θ = sin−1(M/S), where M is the horizontal distance on the Konno–Mead diagram at the midpoint between the maximal and minimal rib cage excursions, and S is the maximal abdomen excursion (Fig. 1). Near the end of each protocol, data for 3 consecutive stable breaths were selected, and the mean was used as a single value for final analysis.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Konno-Mead diagram of abdominal motion versus rib cage motion. The phase angle (θ) is calculated according to the formula, θ = sin−1 (M/S), where M is the horizontal distance on the Konno–Mead diagram at the midpoint between the maximal and minimal rib cage excursions, and S is the maximal abdominal excursion. Asynchrony produces a wide open loop. Synchronous rib cage/abdominal motion has a θ of 0°, and paradoxical motion has a θ of 180°.

Statistical Analysis

The data, collected for 4 protocols (conventional oxygen therapy, HFNC 1 L/kg/min, HFNC 2 L/kg/min, and conventional oxygen therapy) were analyzed among all subjects by repeated measures of analysis of variance with multiple comparisons for effect over time. Statistical calculations were carried out with statistics software (SPSS 11.0.1, SPSS, Chicago, Illinois). Data are expressed as mean (95% CI) unless otherwise indicated. P < .05 was considered statistically significant.

Results

A total of 12 subjects who met inclusion criteria were enrolled in the study. Two subjects were subsequently excluded because they were overly restless, preventing respiratory inductive plethysmography measurements, reducing the study population to 10. Two excluded subjects were observed under conventional oxygen therapy and never experienced further respiratory management. None of the remaining subjects experienced severe upper-airway obstruction or acidosis. We did not observe any apparent harm associated with treatment. Details of each subject are summarized in Table 1. The median (interquartile range) age was 7 (6–14) months. Body weight was 6,527 (5,288–8,788) g, and 7 subjects (70%) were female. The most common inclusion criterion was asynchronous or paradoxical breathing pattern (70%).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Subject Characteristics

Table 2 shows variables measured during conventional and HFNC oxygen therapy for all subjects; changes in values over time are shown in Figures 2 and 3. Compared with the first period of conventional delivery, statistically significant decreases in HFNC at 2 L/kg/min, but not in HFNC at 1 L/kg/min, were detected in breathing frequency (mean [95% CI], 33 [28–33] vs 37 [33–41] breaths/min, P = .01), maximum compartmental amplitude/VT (1.03 [1.01–1.05] vs 1.07 [1.02–1.12], P = .03), phase angle (19° [10–28°] vs 32° [20–45°], P = .036), and minute volume (242 [191–293] vs 303 [223–383] mL/kg, P = .037). No statistically significant difference in any variable was found after comparing data for HFNC at 1 and 2 L/kg/min. During the second period of conventional delivery, breathing frequency was statistically significantly higher than during 2 L/kg/min (36 [31–42] vs 33 [28–33] breaths/min, P = .03). Maximum compartmental amplitude/VT, phase angle, and minute volume, however, did not change after final discontinuation of HFNC. PaCO2 was similar during each protocol. No statistically significant difference in any variable was found after comparing data for the first and second periods of conventional delivery.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Measurement Variables During Conventional Oxygen Therapy and Different Levels of High-Flow Nasal Cannula Delivery

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Changes in variables related to thoraco-abdominal synchrony for conventional oxygen therapy and different levels of high-flow nasal cannula (HFNC) delivery. A: Ratio of maximum compartmental amplitude to tidal volume (MCA/VT). B: Phase angle. Both parameters did not differ between controls. Data are expressed as means and 95% CI.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Changes in ventilation variables among conventional oxygen therapy and different levels of high-flow nasal cannula (HFNC) delivery. A: Breathing frequency. B: Tidal volume (VT). C: Minute volume. D: PaCO2. All parameters did not differ between controls. Data are expressed as means and 95% CI.

Discussion

The major finding of our study is that, for pediatric subjects after cardiac surgery, HFNC oxygen therapy at flow 2 L/kg/min improved thoraco-abdominal synchrony and reduced breathing frequency. To our knowledge, this is the first crossover study to investigate the effect of different HFNC flows on thoraco-abdominal synchrony.

Effect of HFNC on Thoraco-Abdominal Synchrony

Despite an open system, HFNC generates positive airway pressure in a flow-dependent manner.8,11,16 Moreover, unidirectional high gas flow toward the lung during the inspiratory phase offloads the diaphragm and reduces work of breathing.16,19,27,28 Both positive airway pressure and better matching of the patient's inspiratory flow are supposed to eliminate the rib cage lag after the abdominal motion, which is often seen in patients with respiratory failure.20 Reduced nasopharyngeal dead space may be another possible reason for the improvement of thoraco-abdominal synchrony. As seen in our adult study,21 we observed decreased minute volume and breathing frequency, without alteration of PaCO2 during HFNC. It is possible that HFNC improved breathing pattern through washout of airway dead space.

Our finding is also consistent with other studies reporting the favorable effects of HFNC on the breathing pattern of preterm infants. Studying preterm infants requiring supplemental oxygen but not mechanical ventilation, Locke et al22 found a significant flow-dependent decrease in phase angle from 80 to 53° when oxygen was administered through a large-bore nasal cannula at 0.5–2 L/min. In a study of neonates, including some who had undergone mechanical ventilation, de Jongh et al20 observed a small decrease in phase angle from 115 to 87° when HFNC flow increased from 3 to 5 L/min. Compared with studies in preterm infants, we observed a lower phase angle, possibly because we studied older subjects with better lung mechanics and chest wall stability.29 Rather than the small airway obstruction seen in premature infants,30 our population had decreased lung and chest wall compliance induced by edema after cardiac surgery responsive to greater positive airway pressure. Pham et al16 found that HFNC reduced work of breathing both in infants with bronchiolitis and in infants with cardiac problems, although the effects were less prominent in the latter. We can conclude that there are some differences in the mechanisms involved in the improvement of thoraco-abdominal synchrony in preterm infants and in our population.

Optimal Flow During HFNC

HFNC up to 2 L/kg/min could be safely applied, and at this flow, thoraco-abdominal synchrony was statistically significantly better than with conventional oxygen therapy. Testing HFNC flows of 0.3, 0.6, and 1.3 L/kg/min, Locke et al22 observed linear phase angle improvement but were unable to detect a value at which improvement ceased. Meanwhile, testing HFNC flows of 2.0 and 3.3 L/kg/min, de Jongh et al20 discerned only a slight decrease in phase angle. We refrained from testing flow at more than the recommended level of 2 L/kg/min, although an observational study on pediatric HFNC noted flows up to 3 L/kg/min.31 Within safe limits, higher flows that de Jongh et al applied20 should be tested to provide additional evidence.

In a lung-injured animal model, Frizzola et al14 found that the effect of increasing HFNC flow on CO2 removal was independent of mouth opening and tracheal pressure. PaCO2 plateaued, however, once flow reached a certain level, which may be the point at which all dead space is flushed out. Airway pressure also rises flow-dependently during HFNC in adults,11,32,33 children,12,34 and preterm infants.14,34,35 In a recent adult study, Mauri et al36 found that although pressure-related effects, such as oxygenation, end-expiratory lung volume, and lung mechanics, improved linearly, increasing HFNC flow exponentially decreased the work of breathing and minute ventilation, and most of the effects were already obtained at a minimum flow of 30 L/min. The improvement of thoraco-abdominal synchrony over time may possibly be linked to those linear effects, which are related to increasing airway pressure. Even so, we must remain aware that the effects, as well as other factors, can be largely influenced by cannula size,29,35 mouth leakage,11,29 and, as Mauri et al36 observed, significant individual variability of flow, which accounted for the largest physiological improvements.

Strengths and Limitations of This Study

We designed the study so as to both determine and compare the effects of 2 levels of HFNC flow on thoraco-abdominal synchrony for each subject. This made it possible to conduct within-subject comparisons, rather than intergroup comparisons, which would have necessitated a much larger sample size. Using a crossover study design also allowed us to minimize the sequence effect of the 2 different HFNC flows. In theory, flow per se could have contributed to the improvement of breathing pattern.

There are several limitations to this study. First, even in a crossover study, results from a sample of only 10 subjects with mild to moderate respiratory failure is inadequate for broad extrapolation. Studies using larger sample sizes are necessary to determine the optimal level of HFNC and its clinical importance. Second, our population, age 0–28 months, was also age-limited. Because the airway anatomy and respiratory mechanics of babies differ substantially from those of older infants and pre-teen children, extrapolation may not be prudent. Even so, there is no evident relationship between baseline phase angle and age. Third, during each protocol, we collected data from only 3 consecutive breaths, and there is no guarantee that all of these samples were typical; on the other hand, when the samples were collected, 30 min into each protocol, parameters had mostly stabilized.

Clinical Implications

In this study, HFNC at 2 L/kg/min flow improved breathing pattern in pediatric cardiac subjects. Additionally, we observed a significant decrease in breathing frequency with HFNC. Indeed, reduced breathing frequency has been the most salient beneficial clinical effect of HFNC in previous studies for both adults21,37–40 and pediatric subjects.18,41 In an adult clinical study, Sztrymf et al37 concluded that absence of a decrease in respiratory frequency and persistent paradoxical breathing pattern as well as lower oxygenation after HFNC initiation were key and often early observable signs of impending respiratory failure. Our findings indicate that careful physical examination may also be valuable in children as a surrogate as HFNC flow levels are adjusted and used to recognize success or failure of this therapy.

Conclusions

In pediatric subjects after cardiac surgery, HFNC oxygen therapy at 2 L/kg/min flow improved thoraco-abdominal synchrony and decreased breathing frequency. Further studies are required to ascertain optimal flow levels and to predict which types of patients will derive the most benefit from HFNC.

Footnotes

  • Correspondence: Masaji Nishimura, Tokushima Prefectural Central Hospital, 1-10-3 Kuramoto-cho, Tokushima, 770-8539, Japan. E-mail: nmasaji{at}tph.gr.jp.
  • This study was supported by the Department of Emergency and Critical Care Medicine, Tokushima University Graduate School, Tokushima, Japan. The authors have disclosed no conflicts of interest.

  • See the Related Editorial on Page 110

  • Copyright © 2019 by Daedalus Enterprises

References

  1. 1.↵
    1. Nishimura M
    . High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016;61(4):529–541.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    1. Levy SD,
    2. Alladina JW,
    3. Hibbert KA,
    4. Harris RS,
    5. Bajwa EK,
    6. Hess DR
    . High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet 2016;387(10030):1867–1878.
    OpenUrl
  3. 3.
    1. Nedel WL,
    2. Deutschendorf C,
    3. Moraes Rodrigues Filho E
    . High-flow nasal cannula in critically ill subjects with or at risk for respiratory failure: a systematic review and meta-analysis. Respir Care 2017;62(1):123–132.
    OpenUrlAbstract/FREE Full Text
  4. 4.
    1. Ward JJ
    . High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respir Care 2013;58(1):98–122.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Frat JP,
    2. Thille AW,
    3. Mercat A,
    4. Girault C,
    5. Ragot S,
    6. Perbet S,
    7. et al
    . High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Baudin F,
    2. Pouyau R
    . High-flow nasal cannula in the pediatric ICU: popular or efficient? Respir Care 2017;62(8):1116–1117.
    OpenUrlFREE Full Text
  7. 7.
    1. Ramnarayan P,
    2. Schibler A
    . Glass half empty or half full? The story of high-flow nasal cannula therapy in critically ill children. Intensive Care Med 2017;43(2):246–249.
    OpenUrlCrossRef
  8. 8.↵
    1. Hutchings FA,
    2. Hilliard TN,
    3. Davis PJ
    . Heated humidified high-flow nasal cannula therapy in children. Arch Dis Child 2015;100(6):571–575.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Chikata Y,
    2. Izawa M,
    3. Okuda N,
    4. Itagaki T,
    5. Nakataki E,
    6. Onodera M,
    7. et al
    . Humidification performance of two high-flow nasal cannula devices: a bench study. Respir Care 2014;59(8):1186–1190.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Chikata Y,
    2. Ohnishi S,
    3. Nishimura M
    . Humidity and inspired oxygen concentration during high-flow nasal cannula therapy in neonatal and infant lung models. Respir Care 2017;62(5):532–537.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Parke RL,
    2. McGuinness SP
    . Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013;58(10):1621–1624.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Urbano J,
    2. del Castillo J,
    3. López-Herce J,
    4. Gallardo JA,
    5. Solana MJ,
    6. Carrillo Á
    . High-flow oxygen therapy: pressure analysis in a pediatric airway model. Respir Care 2012;57(5):721–726.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Möller W,
    2. Celik G,
    3. Feng S,
    4. Bartenstein P,
    5. Meyer G,
    6. Oliver E,
    7. et al
    . Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol 2015;118(12):1525–1532.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Frizzola M,
    2. Miller TL,
    3. Rodriguez ME,
    4. Zhu Y,
    5. Rojas J,
    6. Hesek A,
    7. et al
    . High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol 2011;46(1):67–74.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Chikata Y,
    2. Onodera M,
    3. Oto J,
    4. Nishimura M
    . FIO2 in an adult model simulating high-flow nasal cannula therapy. Respir Care 2017;62(2):193–198.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Pham TM,
    2. O'Malley L,
    3. Mayfield S,
    4. Martin S,
    5. Schibler A
    . The effect of high flow nasal cannula therapy on the work of breathing in infants with bronchiolitis. Pediatr Pulmonol 2015;50(7):713–720.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Schibler A,
    2. Pham TM,
    3. Dunster KR,
    4. Foster K,
    5. Barlow A,
    6. Gibbons K,
    7. Hough JL
    . Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery. Intensive Care Med 2011;37(5):847–852.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Milési C,
    2. Baleine J,
    3. Matecki S,
    4. Durand S,
    5. Combes C,
    6. Novais AR,
    7. Cambonie G
    . Is treatment with a high flow nasal cannula effective in acute viral bronchiolitis? A physiologic study. Intensive Care Med 2013;39(6):1088–1094.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Tobin MJ,
    2. Jenouri G,
    3. Lind B,
    4. Watson H,
    5. Schneider A,
    6. Sackner MA
    . Validation of respiratory inductive plethysmography in patients with pulmonary disease. Chest 1983;83(4):615–620.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. de Jongh BE,
    2. Locke R,
    3. Mackley A,
    4. Emberger J,
    5. Bostick D,
    6. Stefano J,
    7. et al
    . Work of breathing indices in infants with respiratory insufficiency receiving high-flow nasal cannula and nasal continuous positive airway pressure. J Perinatol 2014;34(1):27–32.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Itagaki T,
    2. Okuda N,
    3. Tsunano Y,
    4. Kohata H,
    5. Nakataki E,
    6. Onodera M,
    7. et al
    . Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically ill patients. Respir Care 2014;59(1):70–74.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Locke RG,
    2. Wolfson MR,
    3. Shaffer TH,
    4. Rubenstein SD,
    5. Greenspan JS
    . Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993;91(1):135–138.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Saslow JG,
    2. Aghai ZH,
    3. Nakhla TA,
    4. Hart JJ,
    5. Lawrysh R,
    6. Stahl GE,
    7. Pyon KH
    . Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol 2006;26(8):476–480.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Nielsen KR,
    2. Ellington LE,
    3. Gray AJ,
    4. Stanberry LI,
    5. Smith LS,
    6. DiBlasi RM
    . Effect of high-flow nasal cannula on expiratory pressure and ventilation in infant, pediatric, and adult models. Respir Care 2018;63(2):147–157.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Luo JC,
    2. Lu MS,
    3. Zhao ZH,
    4. Jiang W,
    5. Xu B,
    6. Weng L,
    7. et al
    . Positive end-expiratory pressure effect of 3 high-flow nasal cannula devices. Respir Care 2017;62(7):888–895.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Sackner MA,
    2. Watson H,
    3. Belsito AS,
    4. Feinerman D,
    5. Suarez M,
    6. Gonzalez G,
    7. et al
    . Calibration of respiratory inductive plethysmograph during natural breathing. J Appl Physiol 1989;66(1):410–420.
    OpenUrlPubMed
  27. 27.↵
    1. Dysart K,
    2. Miller TL,
    3. Wolfson MR,
    4. Shaffer TH
    . Research in high flow therapy: mechanisms of action. Respir Med 2009;103(10):1400–1405.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Lee JH,
    2. Rehder KJ,
    3. Williford L,
    4. Cheifetz IM,
    5. Turner DA
    . Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med 2013;39(2):247–257.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Sivieri EM,
    2. Gerdes JS,
    3. Abbasi S
    . Effect of HFNC flow rate, cannula size, and nares diameter on generated airway pressures: an in vitro study. Pediatr Pulmonol 2013;48(5):506–514.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Gappa M,
    2. Pillow JJ,
    3. Allen J,
    4. Mayer O,
    5. Stocks J
    . Lung function tests in neonates and infants with chronic lung disease: Lung and chest-wall mechanics. Pediatr Pulmonol 2006;41(4):291–317.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Coletti KD,
    2. Bagdure DN,
    3. Walker LK,
    4. Remy KE,
    5. Custer JW
    . High flow nasal cannula utilization in pediatric critical care. Respir Care 2017;62(8):1023–1029.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Ritchie JE,
    2. Williams AB,
    3. Gerard C,
    4. Hockey H
    . Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 2011;39(6):1103–1110.
    OpenUrlPubMed
  33. 33.↵
    1. Parke RL,
    2. Bloch A,
    3. McGuinness SP
    . Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care 2015;60(10):1397–1403.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Hasan RA,
    2. Habib RH
    . Effects of flow rate and airleak at the nares and mouth opening on positive distending pressure delivery using commercially available high-flow nasal cannula systems: a lung model study. Pediatr Crit Care Med 2011;12(1):e29–e33.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Volsko TA,
    2. Fedor K,
    3. Amadei J,
    4. Chatburn RL
    . High flow through a nasal cannula and CPAP effect in a simulated infant model. Respir Care 2011;56(12):1893–1900.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Mauri T,
    2. Alban L,
    3. Turrini C,
    4. Cambiaghi B,
    5. Carlesso E,
    6. Taccone P,
    7. et al
    . Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017;43(10):1453–1463.
    OpenUrl
  37. 37.↵
    1. Sztrymf B,
    2. Messika J,
    3. Bertrand F,
    4. Hurel D,
    5. Leon R,
    6. Dreyfuss D,
    7. Ricard JD
    . Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 2011;37(11):1780–1786.
    OpenUrlCrossRefPubMed
  38. 38.
    1. Sztrymf B,
    2. Messika J,
    3. Mayot T,
    4. Lenglet H,
    5. Dreyfuss D,
    6. Ricard JD
    . Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: a prospective observational study. J Crit Care 2012;27(3):324.e9–e13.
    OpenUrlCrossRefPubMed
  39. 39.
    1. Roca O,
    2. Riera J,
    3. Torres F,
    4. Masclans JR
    . High-flow oxygen therapy in acute respiratory failure. Respir Care 2010;55(4):408–413.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Corley A,
    2. Caruana LR,
    3. Barnett AG,
    4. Tronstad O,
    5. Fraser JF
    . Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth 2011;107(6):998–1004.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Lampland AL,
    2. Plumm B,
    3. Meyers PA,
    4. Worwa CT,
    5. Mammel MC
    . Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr 2009;154(2):177–182.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Respiratory Care: 64 (1)
Respiratory Care
Vol. 64, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effect of High-Flow Nasal Cannula on Thoraco-Abdominal Synchrony in Pediatric Subjects After Cardiac Surgery
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effect of High-Flow Nasal Cannula on Thoraco-Abdominal Synchrony in Pediatric Subjects After Cardiac Surgery
Taiga Itagaki, Nobuto Nakanishi, Nao Okuda, Emiko Nakataki, Mutsuo Onodera, Jun Oto, Masaji Nishimura
Respiratory Care Jan 2019, 64 (1) 10-16; DOI: 10.4187/respcare.06193

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Effect of High-Flow Nasal Cannula on Thoraco-Abdominal Synchrony in Pediatric Subjects After Cardiac Surgery
Taiga Itagaki, Nobuto Nakanishi, Nao Okuda, Emiko Nakataki, Mutsuo Onodera, Jun Oto, Masaji Nishimura
Respiratory Care Jan 2019, 64 (1) 10-16; DOI: 10.4187/respcare.06193
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • high-flow nasal cannula
  • neonates
  • thoraco-abdominal synchrony
  • cardiac surgery
  • oxygen therapy

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire